Self-Expanding Sinus Dilation Technology Offers More With Less
SinuSys Corp. received FDA clearance in December 2013 for its Vent-Os Sinus Dilation System, a novel in-office treatment for patients with chronic rhinosinusitis (CRS) affecting the maxillary sinus that uses a self-expanding, removable capsule and osmotic technology to open the sinuses
You may also be interested in...
Canadian Generics Group Launches Cost-Saving Campaign
The CGPA is drawing attention to the cost savings Canadians can benefit from through the use of generic drugs via a PSA-style digital campaign.
EU Packaging Regulation Presents Challenge And Opportunity For Consumer Health Industry
A proposed new European Union packaging regulation, which introduces environmental and labelling requirements and extended producer responsibility for medicines, medical devices and food supplements, could be challenging for the region's consumer health industry. But it could also be a spur to creativity, argues Chris Whitehouse, chairman and managing director of Whitehouse Communications.
Krka Talks Russia, Ukraine, One Year After Conflict Began
Slovenia’s Krka enjoyed a solid year for its dominant Prescription Pharmaceuticals business, with sales climbing by 7% on the back of growth for all six of its geographic business units.